SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Hazell P. Aust. Prescr. 2022; 45(2): 49-52.

Copyright

(Copyright © 2022, National Prescribing Service (Australia))

DOI

10.18773/austprescr.2022.011

PMID

35592362

PMCID

PMC9081936

Abstract

In adolescence, antidepressants are second-line treatment options after psychological therapy for anxiety and obsessive compulsive disorder. They may be first- or second-line options for severe cases of major depressive disorder. The response to antidepressant treatment is generally good for anxiety and obsessive compulsive disorder, but is less convincing for major depressive disorder. Adolescents who do not respond to an adequate trial of one antidepressant should be referred for a psychiatric opinion. Patients must be monitored for rare but serious adverse effects. These include suicide-related behaviours, switching to mania, and serotonin syndrome.


Language: en

Keywords

adolescent; anxiety disorders; antidepressive drugs; depressive disorder; obsessive compulsive disorder

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print